Based in the United States, Cambrooke Therapeutics is a startup.
Cambrooke Therapeutics develops and supplies medical foods and specialized nutritional products for people with metabolic disorders (such as phenylketonuria/PKU) and other dietary-restricted conditions. Its portfolio includes low-protein foods and specialty medical formulas designed to meet the nutritional needs of patients with inborn errors of metabolism.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.